Expert calls TrumpRx a 'side show’ that won’t benefit most Americans. How to really save big on prescription drugs

Core Insights - TrumpRx was launched on February 5, aiming to reduce prescription drug costs, but experts believe its benefits will be limited to a small number of Americans, potentially leading to higher costs for many without proper comparison shopping [1][2]. Group 1: Overview of TrumpRx - The TrumpRx.gov website lists at least 40 brand-name medications with discounted prices from five pharmaceutical companies, highlighting significant discounts on drugs like Wegovy and fertility medications [2]. - Critics argue that the platform has fundamental flaws that could result in consumers spending more [2]. Group 2: Expert Opinions - Health economist Sean D. Sullivan described TrumpRx as a "side show," indicating it is not a serious effort to lower prescription drug prices for Americans [3]. - Approximately 84% of Americans have prescription drug coverage, and for most, insurance copays are likely to be cheaper than TrumpRx's cash prices [3]. Group 3: Limitations of TrumpRx - TrumpRx is primarily beneficial for cash-paying patients who do not use insurance, which limits its effectiveness for the majority of Americans [3]. - Each product page on TrumpRx includes a warning advising users to check their insurance copay first, as it may be lower than the TrumpRx price [4]. Group 4: Potential Risks - Purchases made through TrumpRx may not contribute towards insurance deductibles or out-of-pocket maximums, meaning that even if a TrumpRx price appears lower than a copay, using insurance could result in greater savings [5]. - Law professor Rachel Sachs cautioned that patients might mistakenly believe they are getting a good deal and end up financially worse off [4]. Group 5: Target Beneficiaries - TrumpRx could provide real savings for specific groups, particularly those needing obesity drugs and fertility medications that are often not covered by insurance [6].